CUMBERLAND PHARMACEUTICALS INC·4

Dec 3, 5:15 PM ET

Hamm John M. 4

4 · CUMBERLAND PHARMACEUTICALS INC · Filed Dec 3, 2021

Insider Transaction Report

Form 4
Period: 2021-11-23
Hamm John M.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2021-11-23$2.35/sh+3,800$8,9306,800 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION